{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:42:59Z","timestamp":1789454579182,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drusen are retinal deposits comprising cell debris, immune material and complement that are characteristic of macular degeneration but also found in glomerulonephritis. This was a pilot cross-sectional study to determine how often drusen occurred in IgA glomerulonephritis and their clinical significance. Study participants underwent non-mydriatic retinal photography, and their deidentified retinal images were examined for drusen by two trained graders, who compared central drusen counts, counts\u2009\u2265\u200910 and drusen size with those of matched controls. The cohort comprised 122 individuals with IgA glomerulonephritis including 89 males (73%), 49 individuals (40%) of East Asian or Southern European ancestry, with an overall median age of 54\u00a0years (34\u201364), and median disease duration of 9\u00a0years (4\u201317). Thirty-nine (33%) had an eGFR\u2009&lt;\u200960\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> and 72 had previously reached kidney failure (61%). Overall mean drusen counts were higher in IgA glomerulonephritis (9\u2009\u00b1\u200927) than controls (2\u2009\u00b1\u20097, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Central counts\u2009\u2265\u200910 were also more common (OR\u2009=\u20093.31 (1.42\u20137.73, <jats:italic>p<\/jats:italic>\u2009=\u20090.006), and were associated with longer disease duration (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) but not kidney failure (<jats:italic>p<\/jats:italic>\u2009=\u20090.31). Larger drusen were associated with more mesangial IgA staining (<jats:italic>p<\/jats:italic>\u2009=\u20090.004). Increased drusen counts were also present in IgA glomerulonephritis secondary to Crohn\u2019s disease but not with Henoch-Schonlein purpura. The finding of retinal drusen in IgA glomerulonephritis is consistent with complement activation and represents a model for better understanding glomerular immune deposition and a supporting\u00a0argument for treatment with anti-complement therapies.<\/jats:p>","DOI":"10.1038\/s41598-022-21386-y","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T10:03:04Z","timestamp":1667210584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis"],"prefix":"10.1038","volume":"12","author":[{"given":"P.","family":"Harraka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Akom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb","family":"Colville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Catran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Pianta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ierino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Skene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Savige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"21386_CR1","first-page":"709","volume":"64","author":"G D'Amico","year":"1987","unstructured":"D\u2019Amico, G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J. Med. 64, 709\u2013727 (1987).","journal-title":"Q J. Med."},{"key":"21386_CR2","doi-asserted-by":"publisher","first-page":"e1002765","DOI":"10.1371\/journal.pgen.1002765","volume":"8","author":"K Kiryluk","year":"2012","unstructured":"Kiryluk, K. et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 8, e1002765. https:\/\/doi.org\/10.1371\/journal.pgen.1002765 (2012).","journal-title":"PLoS Genet."},{"key":"21386_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2000.8966","volume":"36","author":"G D'Amico","year":"2000","unstructured":"D\u2019Amico, G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am. J. Kidney Dis. 36, 227\u2013237. https:\/\/doi.org\/10.1053\/ajkd.2000.8966 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"21386_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.1997.361","volume":"52","author":"M Tomana","year":"1997","unstructured":"Tomana, M. et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509\u2013516. https:\/\/doi.org\/10.1038\/ki.1997.361 (1997).","journal-title":"Kidney Int."},{"key":"21386_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI5535","volume":"104","author":"M Tomana","year":"1999","unstructured":"Tomana, M. et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73\u201381. https:\/\/doi.org\/10.1172\/JCI5535 (1999).","journal-title":"J. Clin. Invest."},{"key":"21386_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.1830170304","volume":"17","author":"PS Hiemstra","year":"1987","unstructured":"Hiemstra, P. S., Gorter, A., Stuurman, M. E., Van Es, L. A. & Daha, M. R. Activation of the alternative pathway of complement by human serum IgA. Eur. J. Immunol. 17, 321\u2013326. https:\/\/doi.org\/10.1002\/eji.1830170304 (1987).","journal-title":"Eur. J. Immunol."},{"key":"21386_CR7","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","volume":"167","author":"A Roos","year":"2001","unstructured":"Roos, A. et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167, 2861\u20132868. https:\/\/doi.org\/10.4049\/jimmunol.167.5.2861 (2001).","journal-title":"J. Immunol."},{"key":"21386_CR8","doi-asserted-by":"publisher","first-page":"e40495","DOI":"10.1371\/journal.pone.0040495","volume":"7","author":"SJ Kim","year":"2012","unstructured":"Kim, S. J. et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One 7, e40495. https:\/\/doi.org\/10.1371\/journal.pone.0040495 (2012).","journal-title":"PLoS One"},{"key":"21386_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0272-6386(99)70417-8","volume":"33","author":"F Scolari","year":"1999","unstructured":"Scolari, F. et al. Familial clustering of IgA nephropathy: Further evidence in an Italian population. Am. J. Kidney Dis. 33, 857\u2013865. https:\/\/doi.org\/10.1016\/s0272-6386(99)70417-8 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"21386_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrneph.2012.58","volume":"8","author":"KN Lai","year":"2012","unstructured":"Lai, K. N. Pathogenesis of IgA nephropathy. Nat. Rev. Nephrol. 8, 275\u2013283. https:\/\/doi.org\/10.1038\/nrneph.2012.58 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"21386_CR11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk, K. et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 46, 1187\u20131196. https:\/\/doi.org\/10.1038\/ng.3118 (2014).","journal-title":"Nat. Genet."},{"key":"21386_CR12","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1681\/ASN.2007020241","volume":"18","author":"AD Paterson","year":"2007","unstructured":"Paterson, A. D. et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J. Am. Soc. Nephrol. 18, 2408\u20132415. https:\/\/doi.org\/10.1681\/ASN.2007020241 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"21386_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 43, 321\u2013327. https:\/\/doi.org\/10.1038\/ng.787 (2011).","journal-title":"Nat. Genet."},{"key":"21386_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/ejhg.2015.52","volume":"23","author":"A Milillo","year":"2015","unstructured":"Milillo, A. et al. A SPRY2 mutation leading to MAPK\/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. Eur. J. Hum. Genet. 23, 1673\u20131678. https:\/\/doi.org\/10.1038\/ejhg.2015.52 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"21386_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.1992.412","volume":"42","author":"K Yoshioka","year":"1992","unstructured":"Yoshioka, K. et al. IgA nephropathy in patients with congenital C9 deficiency. Kidney Int. 42, 1253\u20131258. https:\/\/doi.org\/10.1038\/ki.1992.412 (1992).","journal-title":"Kidney Int."},{"key":"21386_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.1996.359","volume":"50","author":"R Topaloglu","year":"1996","unstructured":"Topaloglu, R. et al. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 50, 635\u2013642. https:\/\/doi.org\/10.1038\/ki.1996.359 (1996).","journal-title":"Kidney Int."},{"key":"21386_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000186535","volume":"59","author":"K Imai","year":"1991","unstructured":"Imai, K. et al. Homozygous C3 deficiency associated with IgA nephropathy. Nephron 59, 148\u2013152. https:\/\/doi.org\/10.1159\/000186535 (1991).","journal-title":"Nephron"},{"key":"21386_CR18","first-page":"208","volume":"12","author":"DK Jin","year":"1992","unstructured":"Jin, D. K., Kohsaka, T., Jun, A. & Kobayashi, N. Complement 4 gene deletion in patients with IgA nephropathy and Henoch-Schonlein nephritis. Child Nephrol. Urol. 12, 208\u2013211 (1992).","journal-title":"Child Nephrol. Urol."},{"key":"21386_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00000441-199102000-00006","volume":"301","author":"RJ Wyatt","year":"1991","unstructured":"Wyatt, R. J., Julian, B. A. & Rivas, M. L. Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy. Am. J. Med. Sci. 301, 115\u2013123. https:\/\/doi.org\/10.1097\/00000441-199102000-00006 (1991).","journal-title":"Am. J. Med. Sci."},{"key":"21386_CR20","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.jcjo.2017.07.014","volume":"53","author":"N Cetin","year":"2018","unstructured":"Cetin, N., Basmak, H., Gencler, A. & Acikalin, M. F. Perimacular drusenoid deposits in a child with IgA nephropathy. Can. J. Ophthalmol. 53, e71\u2013e74. https:\/\/doi.org\/10.1016\/j.jcjo.2017.07.014 (2018).","journal-title":"Can. J. Ophthalmol."},{"key":"21386_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamaophthalmol.2014.387","volume":"132","author":"DR Lally","year":"2014","unstructured":"Lally, D. R. & Baumal, C. Subretinal drusenoid deposits associated with complement-mediated IgA nephropathy. JAMA Ophthalmol. 132, 775\u2013777. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.387 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"21386_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/09273948.2019.1651873","volume":"28","author":"JS Takhar","year":"2020","unstructured":"Takhar, J. S. & Gonzales, J. A. IgA nephropathy-associated uveitis: A case presentation. Ocul. Immunol. Inflamm. 28, 1125\u20131128. https:\/\/doi.org\/10.1080\/09273948.2019.1651873 (2020).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"21386_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajo.2016.11.014","volume":"175","author":"A Invernizzi","year":"2017","unstructured":"Invernizzi, A. et al. Drusen-like deposits in young adults diagnosed with systemic lupus erythematosus. Am. J. Ophthalmol. 175, 68\u201376. https:\/\/doi.org\/10.1016\/j.ajo.2016.11.014 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"21386_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjo.73.4.297","volume":"73","author":"J Duvall-Young","year":"1989","unstructured":"Duvall-Young, J., MacDonald, M. K. & McKechnie, N. M. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: A histopathological report. Br. J. Ophthalmol. 73, 297\u2013302. https:\/\/doi.org\/10.1136\/bjo.73.4.297 (1989).","journal-title":"Br. J. Ophthalmol."},{"key":"21386_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/13816810.2015.1101777","volume":"37","author":"J Savige","year":"2016","unstructured":"Savige, J. et al. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Ophthalmic Genet. 37, 369\u2013376. https:\/\/doi.org\/10.3109\/13816810.2015.1101777 (2016).","journal-title":"Ophthalmic Genet."},{"key":"21386_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/eye.2001.142","volume":"15","author":"RF Mullins","year":"2001","unstructured":"Mullins, R. F., Aptsiauri, N. & Hageman, G. S. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond.) 15, 390\u2013395. https:\/\/doi.org\/10.1038\/eye.2001.142 (2001).","journal-title":"Eye (Lond.)"},{"key":"21386_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"RF Mullins","year":"2000","unstructured":"Mullins, R. F., Russell, S. R., Anderson, D. H. & Hageman, G. S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835\u2013846 (2000).","journal-title":"FASEB J."},{"key":"21386_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","volume":"15","author":"LG Fritsche","year":"2014","unstructured":"Fritsche, L. G. et al. Age-related macular degeneration: Genetics and biology coming together. Annu. Rev. Genomics Hum. Genet. 15, 151\u2013171. https:\/\/doi.org\/10.1146\/annurev-genom-090413-025610 (2014).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"21386_CR29","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.2215\/CJN.10321110","volume":"6","author":"R Deva","year":"2011","unstructured":"Deva, R. et al. Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. Clin. J. Am. Soc. Nephrol. 6, 1866\u20131871. https:\/\/doi.org\/10.2215\/CJN.10321110 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"21386_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/09286580701344381","volume":"14","author":"R Klein","year":"2007","unstructured":"Klein, R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 14, 184\u2013187. https:\/\/doi.org\/10.1080\/09286580701344381 (2007).","journal-title":"Ophthalmic Epidemiol."},{"key":"21386_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","volume":"3","author":"KL Pennington","year":"2016","unstructured":"Pennington, K. L. & DeAngelis, M. M. Epidemiology of age-related macular degeneration (AMD): Associations with cardiovascular disease phenotypes and lipid factors. Eye Vis. (Lond.) 3, 34. https:\/\/doi.org\/10.1186\/s40662-016-0063-5 (2016).","journal-title":"Eye Vis. (Lond.)"},{"key":"21386_CR32","doi-asserted-by":"publisher","first-page":"R246","DOI":"10.1093\/hmg\/ddx343","volume":"26","author":"MM DeAngelis","year":"2017","unstructured":"DeAngelis, M. M. et al. Genetics of age-related macular degeneration (AMD). Hum. Mol. Genet. 26, R246. https:\/\/doi.org\/10.1093\/hmg\/ddx343 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"21386_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 134\u2013143. https:\/\/doi.org\/10.1038\/ng.3448 (2016).","journal-title":"Nat. Genet."},{"key":"21386_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jcp.21742","volume":"220","author":"J Wang","year":"2009","unstructured":"Wang, J. et al. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages\/microglia: Another mechanism of complement activation in age-related macular degeneration. J. Cell Physiol. 220, 119\u2013128. https:\/\/doi.org\/10.1002\/jcp.21742 (2009).","journal-title":"J. Cell Physiol."},{"key":"21386_CR35","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1073\/pnas.0912702107","volume":"107","author":"W Chen","year":"2010","unstructured":"Chen, W. et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 107, 7401\u20137406. https:\/\/doi.org\/10.1073\/pnas.0912702107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21386_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0161-6420(91)32186-9","volume":"98","author":"R Klein","year":"1991","unstructured":"Klein, R. et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98, 1128\u20131134 (1991).","journal-title":"Ophthalmology"},{"key":"21386_CR37","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/bjophthalmol-2013-304556","volume":"98","author":"I Mantel","year":"2014","unstructured":"Mantel, I., Niderprim, S. A., Gianniou, C., Deli, A. & Ambresin, A. Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen. Br. J. Ophthalmol. 98, 1192\u20131196. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304556 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"21386_CR38","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen, S. et al. EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann. Rheum. Dis. 65, 936\u2013941. https:\/\/doi.org\/10.1136\/ard.2005.046300 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"21386_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/bjo.85.10.1153","volume":"85","author":"Y Oshima","year":"2001","unstructured":"Oshima, Y. et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br. J. Ophthalmol. 85, 1153\u20131157 (2001).","journal-title":"Br. J. Ophthalmol."},{"key":"21386_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines, J. L. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419\u2013421. https:\/\/doi.org\/10.1126\/science.1110359 (2005).","journal-title":"Science"},{"key":"21386_CR41","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman, G. S. et al. A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 102, 7227\u20137232. https:\/\/doi.org\/10.1073\/pnas.0501536102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"21386_CR42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.1133807","volume":"314","author":"A Dewan","year":"2006","unstructured":"Dewan, A. et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314, 989\u2013992. https:\/\/doi.org\/10.1126\/science.1133807 (2006).","journal-title":"Science"},{"key":"21386_CR43","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.04.017","author":"J Savige","year":"2021","unstructured":"Savige, J. & Harraka, P. Pathogenic variants in the genes affected in alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: A review. Am. J. Kidney Dis. https:\/\/doi.org\/10.1053\/j.ajkd.2021.04.017 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"21386_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3928\/01913913-20061101-12","volume":"43","author":"M Taban","year":"2006","unstructured":"Taban, M., Chand, D. & Sears, J. E. Ocular findings in IgA nephropathy with renal failure and hypertension. J. Pediatr. Ophthalmol. Strabismus 43, 378\u2013380. https:\/\/doi.org\/10.3928\/01913913-20061101-12 (2006).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"21386_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1055\/s-2000-10577","volume":"216","author":"TJ Wolfensberger","year":"2000","unstructured":"Wolfensberger, T. J., Piguet, B., Gregor, Z. J. & Bird, A. C. Retinal vasculopathy associated with Berger\u2019s IgA nephropathy. Klin. Monbl. Augenheilkd. 216, 334\u2013338. https:\/\/doi.org\/10.1055\/s-2000-10577 (2000).","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"21386_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12886-021-01935-1","volume":"21","author":"K El Matri","year":"2021","unstructured":"El Matri, K., Amoroso, F., Zambrowski, O., Miere, A. & Souied, E. H. Multimodal imaging of bilateral ischemic retinal vasculopathy associated with Berger\u2019s IgA nephropathy: case report. BMC Ophthalmol. 21, 204. https:\/\/doi.org\/10.1186\/s12886-021-01935-1 (2021).","journal-title":"BMC Ophthalmol."},{"key":"21386_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ekir.2022.01.1063","volume":"7","author":"YJ Ham","year":"2022","unstructured":"Ham, Y. J. et al. Retinal drusen are more common and larger in systemic lupus erythematosus with renal impairment. Kidney Int. Rep. 7, 848\u2013856. https:\/\/doi.org\/10.1016\/j.ekir.2022.01.1063 (2022).","journal-title":"Kidney Int. Rep."},{"key":"21386_CR48","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.1038\/s41598-022-12111-w","volume":"12","author":"P Harraka","year":"2022","unstructured":"Harraka, P. et al. Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis. Sci. Rep. 12, 8234. https:\/\/doi.org\/10.1038\/s41598-022-12111-w (2022).","journal-title":"Sci. Rep."},{"key":"21386_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","volume":"10","author":"DV Rizk","year":"2019","unstructured":"Rizk, D. V. et al. The emerging role of complement proteins as a target for therapy of IgA nephropathy. Front. Immunol. 10, 504. https:\/\/doi.org\/10.3389\/fimmu.2019.00504 (2019).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21386-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T11:09:21Z","timestamp":1667214561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21386-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18301"}}